Dr. Anita Goel is a globally recognized leader in the emerging field of nanobiophysics—a new science at the convergence of physics, nanotechnology, and biomedicine. She founded Nanobiosym to integrate these three fields to reveal new scientific solutions to the world’s most pressing challenges.
Her pioneering contributions to nanotechnology and nanobiophysics have been recognized globally by prestigious honors and awards including multiple awards from US Government agencies such as Defense Advanced Research Projects Agency (DARPA), Department of Defense (DOD), Department of Energy (DOE), Air Force Office of Scientific Research (AFOSR) and US Defense Threat Reduction Agency (DTRA).
She established Nanobiosym® Diagnostics to commercialize the Gene-RADAR® technology platform to empower people worldwide with portable, rapid and accurate information about their own health. Employing the latest advances in nanotechnology, Gene-RADAR® is a fully portable, chip-based diagnostic that can recognize any disease with a genetic fingerprint from a single drop of blood or saliva without the need for lab infrastructure, trained health care personnel, electricity or running water.
Dr. Goel was named as one of the world’s “Top 35 Science and Technology Innovators” by MIT Technology Review.
She holds a PhD in Physics from Harvard University, an MD from the Harvard-MIT Joint Division of Health Sciences & Technology (HST), and a BS in Physics with Honors and Distinction from Stanford University.
Dr. Goel created the Nanobiosym Global Initiative to bring emerging technologies into emerging economies by forming innovative public-private partnerships with governments, NGOs, industries, academia and global thought leaders across the world. She has a special interest in bringing disruptive technologies like Gene-RADAR® to address the critical unmet needs of people at the bottom of the pyramid in both the developed and developing world.
